Hey Folks, Michael Reece here,
I'm brining you an important update on Modular Medical (Nasdaq: MODD).
MODD today announced the results of an independent market research study highlighting positive payor receptivity to its FDA-cleared Pivot™ tubeless patch pump, reinforcing the company's commercialization strategy and reimbursement outlook.
News Link Here - snapshot below
Modular Medical Receives Research Demonstrating Positive
Payor Reception of Pivot Tubeless Patch Pump
According to the independent study, payors viewed Pivot™ as a differentiated insulin pump with a simplified user experience and meaningful reimbursement potential through existing pharmacy benefit channels. The findings also support Modular Medical's commercialization strategy and suggest favorable positioning as the company expands market access.
Key Takeaways
Independent Validation: Third-party research supports the company's commercialization strategy.
Positive Payor Reception: Favorable feedback on reimbursement and pharmacy-channel access.
Market Opportunity: Respondents viewed Pivot™ as a differentiated product addressing unmet patient needs.
While commercialization remains in its early stages, today's independent findings provide further validation of the company's market access strategy.
The Bottom Line…
With FDA clearance secured, commercial rollout underway, and third-party validation supporting its strategy, Modular Medical continues to build momentum.
We'll continue monitoring MODD as additional catalysts emerge.
Michael Reece
Editor, Financial Driven Research
© 2026 FinancialDrivenResearch.com. All rights reserved. You are receiving this e-mail as part of your subscription to FinancialDrivenResearch.com. Nothing in this e-mail should be considered personalized financial advice. We are neither a registered investment adviser nor a broker/dealer. Readers are advised that this electronic publication is issued solely for information purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any security. FDR is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. This communication is sponsored. Pursuant to an agreement between FDR and STM LLC. FDR has been compensated fifteen thousand USD to publicly disseminate information about MODD via digital communications, for a period beginning on 7/14/26 and ending on 7/15/26. We own zero shares of MODD.